Immunome, Inc. (IMNM) Financials
IMNM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 93.2 million | 87.1 million |
| 2023-06-30 | 41.4 million | 32.1 million |
| 2023-03-31 | 48.1 million | 34.3 million |
| 2022-12-31 | 24.0 million | 7.4 million |
IMNM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -8.7 million | 1.1 million |
| 2023-06-30 | -6.0 million | 1.0 million |
| 2023-03-31 | 24.1 million | 1.2 million |
| 2022-12-31 | -6.8 million | 1.4 million |
IMNM Net Income
No data available :(
IMNM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 90.6 million | - | 371000 |
| 2023-06-30 | 38.4 million | - | 489000 |
| 2023-03-31 | 44.4 million | - | 236000 |
| 2022-12-31 | 20.3 million | - | 293000 |
IMNM Shares Outstanding
IMNM Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 36000 | 3.8 million | 4.4 million | - |
| 2023-06-30 | 340000 | 5.7 million | 4.3 million | - |
| 2023-03-31 | 106000 | 3.9 million | 2.9 million | - |
| 2022-12-31 | 72000 | 4.3 million | 3.5 million | - |
IMNM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 3.6 million | 166000 |
| 2023-06-30 | 4.3 million | 157000 |
| 2023-03-31 | 2.4 million | 148000 |
| 2022-12-31 | - | 260000 |
IMNM
Price: $15.75
52 week price:
Earnings Per Share: -1.80 USD
P/E Ratio: -12.84
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 8759
Market Capitalization: 1.2 billion